Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 10-year efficacy and late normal tissue effects from a multicentre, open-label, non-inferiority, phase 3, randomised controlled trial and 5-year efficacy results from a randomised axillary substudy.

Brunt AM, Cafferty FH, Kirby AM, Patel J, Sydenham MA, Haviland JS, Griffin S, Chivardi C, Fleming H, Coles CE, Bloomfield DJ, Chan C, Cleator S, Goodman A, Griffin CL, Kirwan CC, Nabi Z, Sawyer E, Somaiah N, Syndikus I, Venables K, Wheatley DA, Yarnold JR, Bliss JM

Open source

DOI: 10.1016/s1470-2045(26)00076-8
Published: 2026 Jun
Container: The Lancet. Oncology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-26-00076-8,
  title = {Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 10-year efficacy and late normal tissue effects from a multicentre, open-label, non-inferiority, phase 3, randomised controlled trial and 5-year efficacy results from a randomised axillary substudy.},
  author = {Brunt AM and Cafferty FH and Kirby AM and Patel J and Sydenham MA and Haviland JS and Griffin S and Chivardi C and Fleming H and Coles CE and Bloomfield DJ and Chan C and Cleator S and Goodman A and Griffin CL and Kirwan CC and Nabi Z and Sawyer E and Somaiah N and Syndikus I and Venables K and Wheatley DA and Yarnold JR and Bliss JM},
  year = {2026},
  journal = {The Lancet. Oncology},
  doi = {10.1016/s1470-2045(26)00076-8},
  url = {https://doi.org/10.1016/s1470-2045(26)00076-8}
}

RIS

TY  - JOUR
TI  - Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 10-year efficacy and late normal tissue effects from a multicentre, open-label, non-inferiority, phase 3, randomised controlled trial and 5-year efficacy results from a randomised axillary substudy.
AU  - Brunt AM
AU  - Cafferty FH
AU  - Kirby AM
AU  - Patel J
AU  - Sydenham MA
AU  - Haviland JS
AU  - Griffin S
AU  - Chivardi C
AU  - Fleming H
AU  - Coles CE
AU  - Bloomfield DJ
AU  - Chan C
AU  - Cleator S
AU  - Goodman A
AU  - Griffin CL
AU  - Kirwan CC
AU  - Nabi Z
AU  - Sawyer E
AU  - Somaiah N
AU  - Syndikus I
AU  - Venables K
AU  - Wheatley DA
AU  - Yarnold JR
AU  - Bliss JM
PY  - 2026
JO  - The Lancet. Oncology
DO  - 10.1016/s1470-2045(26)00076-8
UR  - https://doi.org/10.1016/s1470-2045(26)00076-8
ER  -

APA

AM, B., FH, C., AM, K., J, P., MA, S., JS, H., S, G., C, C., H, F., CE, C., DJ, B., C, C., S, C., A, G., CL, G., CC, K., Z, N., E, S., N, S., I, S., K, V., DA, W., JR, Y., & JM, B. (2026). Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 10-year efficacy and late normal tissue effects from a multicentre, open-label, non-inferiority, phase 3, randomised controlled trial and 5-year efficacy results from a randomised axillary substudy.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(26)00076-8

Source records

pubmed · retrieved 2026-09-26T21:22:55.557Z
europe-pmc · retrieved 2026-09-26T21:22:55.580Z